Clinical verification of 18F-DCFPyL PET-detected lesions in patients with biochemically recurrent prostate cancer-Reference-Cited by-同舟云学术

Clinical verification of 18F-DCFPyL PET-detected lesions in patients with biochemically recurrent prostate cancer

Published:2020-10-06 Issue:10 Volume:15 Page:e0239414
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Meijer Dennie^ORCID,Jansen Bernard H. E.,Wondergem Maurits,Bodar Yves J. L.,Srbljin Sandra,Vellekoop Annelies E.,Keizer Bram,van der Zant Friso M.,Hoekstra Otto S.,Nieuwenhuijzen Jakko A.,Dahele Max^ORCID,Vis André N.,Oprea-Lager Daniela E.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference51 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;F Bray;CA Cancer J Clin,2018

2. Cancer statistics, 2019;RL Siegel;CA Cancer J Clin,2019

3. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent;N Mottet;Eur Urol,2017

4. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes;MS Cookson;J Urol,2007

5. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer;A Heidenreich;Eur Urol,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 68Ga-PSMA PET/CT in Recurrent Prostate Cancer after Radical Prostatectomy Using PSMA-RADS Version 2.0;Diagnostics;2024-06-19

2. Prostate-specific Membrane Antigen Reporting and Data System Version 2.0;European Urology;2023-11

3. In vitro and in vivo comparative study of 68Ga-labeled DOTA-, NOTA-, and HBEDCC-chelated radiotracers targeting prostate-specific membrane antigen;Journal of Radioanalytical and Nuclear Chemistry;2023-01-19

4. A Unique Core–Shell Structured, Glycol Chitosan-Based Nanoparticle Achieves Cancer-Selective Gene Delivery with Reduced Off-Target Effects;Pharmaceutics;2022-02-07

5. [18F]DCFPyL PET/CT for Imaging of Prostate Cancer;Nuklearmedizin - NuclearMedicine;2022-01-14